Clinical trial
PPD™ CorEvitas™ International Alzheimer's (ALZ) Drug Safety and Effectiveness Registry
NCT07420075 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PPD™ CorEvitas™ International Alzheimer's (ALZ) Drug Safety and Effectiveness Registry
- Lead sponsor
- CorEvitas
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- November 24, 2025
- Completion date
- December 31, 2099
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.